Stockscreener 앱 받기
10.94
3.36%
-0.38
시장 영업 전:
10.94
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
How Fulcrum Therapeutics Inc. stock performs in stagflation2025 Dividend Review & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Will Fulcrum Therapeutics Inc. stock benefit from AI adoptionSwing Trade & Stepwise Trade Signal Guides - moha.gov.vn
Contrasting Fulcrum Therapeutics (NASDAQ:FULC) and TG Therapeutics (NASDAQ:TGTX) - Defense World
Why Fulcrum Therapeutics Inc. stock is a must watch in 2025Weekly Stock Analysis & Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Fulcrum Therapeutics Inc (FULC) expanding its growth trajectory ahead - Setenews
Fulcrum Therapeutics (NASDAQ:FULC) Now Covered by Truist Financial - Defense World
Fulcrum Therapeutics stock price target raised to $18 from $12 at H.C. Wainwright - Investing.com Canada
Truist Securities Initiates Coverage of Fulcrum Therapeutics (FULC) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Fulcrum Therapeutics (FULC) Buy Recommendation - Nasdaq
Truist Securities Initiates Buy Rating on Fulcrum Therapeutics (FULC) | FULC Stock News - GuruFocus
FULC Stock Boosted: HC Wainwright & Co. Raises Price Target to $ - GuruFocus
Truist Securities initiates coverage on Fulcrum Therapeutics stock with Buy rating - Investing.com UK
Insider Sell Alert: Robert Gould Sells 15,000 Shares of Fulcrum Therapeutics Inc (FULC) - GuruFocus
Fulcrum Therapeutics Director Sells 15,000 Shares - TradingView
[Form 4] Fulcrum Therapeutics, Inc. Insider Trading Activity - Stock Titan
Dir Gould Sells 15,000 ($165.5K) Of Fulcrum Therapeutics Inc [FULC] - TradingView
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC) and Arrowhead Pharmaceuticals (ARWR) - The Globe and Mail
Will Fulcrum Therapeutics Inc. stock deliver consistent dividends2025 Winners & Losers & Long-Term Growth Plans - newser.com
How Fulcrum Therapeutics Inc. stock valuations compare to rivals2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Will Fulcrum Therapeutics Inc. stock gain from strong economyRate Hike & Low Risk Entry Point Tips - newser.com
What date does Fulcrum Therapeutics's (FULC) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
How Fulcrum Therapeutics Inc. stock compares to growth peersEarnings Recap Report & Real-Time Volume Triggers - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Year in Review & Stock Portfolio Risk Control - newser.com
Is Fulcrum Therapeutics Inc. stock attractive for passive investorsJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Will Fulcrum Therapeutics Inc. stock beat EPS estimatesQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily
Identifying reversal signals in Fulcrum Therapeutics Inc.Weekly Market Report & Verified Stock Trade Ideas - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chartTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
Multi asset correlation models including Fulcrum Therapeutics Inc.Quarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Datanomix and Fulcrum Modernize Manufacturing Tech Stacks with Seamless ERP + Production Monitoring Integration - GlobeNewswire Inc.
How Fulcrum Therapeutics Inc. stock responds to policy changesQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityBond Market & Daily Growth Stock Tips - newser.com
0.45%
1.13%
자본화:
|
볼륨(24시간):